Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people taking Wegovy do report changes to their menstrual cycle, including lighter periods, irregular timing, or, less commonly, periods stopping altogether. This is not listed as a direct side effect of semaglutide itself, but rapid weight loss can disrupt the hormones that regulate your cycle, and Wegovy is a powerful weight-loss medicine. If your periods change noticeably after starting treatment, it is worth discussing with your prescribing clinician rather than assuming the change is harmless. These are prescription-only medicines, and any new or unexpected symptom warrants a proper clinical conversation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Fat tissue is not inert. It produces and stores oestrogen, so when body weight falls quickly, circulating oestrogen levels can drop too. The hypothalamic-pituitary-ovarian axis, the hormonal chain that orchestrates your cycle, is sensitive to energy availability and body-fat percentage. Lose weight rapidly and the brain may interpret this as a period of physiological stress, dialling down reproductive signalling as a result.
This is the same mechanism that causes menstrual disruption in people who lose weight through very-low-calorie diets or intensive exercise. Wegovy accelerates weight loss substantially: the STEP 1 clinical trial, published in the New England Journal of Medicine, found an average reduction of around 15% of body weight over 68 weeks at the 2.4mg maintenance dose. For someone carrying enough adipose tissue to influence hormone levels, that scale of change can be meaningful for their cycle. Read more about how the medicine works on our semaglutide overview.
Lighter periods, changes in cycle length, or a skipped period are the most commonly reported patterns. A complete stop, referred to clinically as amenorrhoea, is less frequent and more likely to occur during the fastest phase of weight reduction, typically in the first few months of dose escalation.
Here is where things get counterintuitive. For many people, weight loss actually restores or improves reproductive function rather than suppressing it. This is particularly relevant for those with polycystic ovary syndrome (PCOS), where excess weight contributes to insulin resistance and hormonal imbalance that can itself stop ovulation. As weight falls and insulin sensitivity improves, ovulation can resume, sometimes before a person realises it has.
This matters practically. Someone who has not had regular periods due to PCOS may start ovulating again on Wegovy before their cycle becomes obviously regular. If you are not planning a pregnancy, reliable contraception from the moment you start treatment is essential. The NHS semaglutide medicines page recommends using effective contraception throughout treatment.
There is a separate and specific point about oral contraceptive pills and tirzepatide (Mounjaro), but for semaglutide the clinical concern is different: it is about restored fertility in people who assumed they were not ovulating, rather than a confirmed reduction in pill absorption. Our page on Wegovy and periods covers the contraception question in more depth, and if you are specifically interested in cycle changes from day one of treatment, the detail is on our can Wegovy cause periods page.
Not every cycle change requires urgent action, but none should be dismissed outright. A practical way to think about it: one slightly different cycle during early dose escalation is worth noting but not panicking over. Two or three consecutive cycles that are significantly different from your baseline, periods that stop entirely for more than three months, or any bleeding that is unusually heavy or prolonged, all of these deserve a clinical conversation sooner rather than later.
There are other causes of amenorrhoea that have nothing to do with weight loss, including thyroid conditions, premature ovarian insufficiency, and, of course, pregnancy. If your periods stop while on Wegovy, a pregnancy test is a sensible and immediate first step, because improved fertility means the possibility should not be ruled out. Our page on Wegovy and endometriosis touches on related hormonal considerations for people with that condition.
The question of whether semaglutide stops periods does not have one fixed answer. For most people the answer is no, or not directly; for some the answer is yes, because of rapid weight loss; and for a subset the more relevant change is periods restarting, not stopping. If you are uncertain where your experience fits, our page exploring how Wegovy affects periods broadly may help frame the picture. Persistent changes, particularly amenorrhoea lasting more than 12 weeks, should be investigated by a doctor, irrespective of Wegovy.
Wegovy is a prescription medicine, and the prescriber who reviews your treatment is the right person to assess whether a menstrual change is weight-related, medicine-related, or something else entirely. Stopping treatment without clinical guidance is not the answer, but neither is carrying on with an unexplained change and hoping it resolves. If cost or access to a GP is a barrier, a clinically reviewed private service gives you a direct line to a prescriber. At nume, a real clinician, not automated software, reviews every consultation. Our Wegovy treatment page explains how the process works from first contact through to ongoing clinical support.
For a fuller look at all the options available to you, our weight-loss treatments overview sets out the licensed medicines and what to expect from each. If you have reached the point of wanting clinical input, you can speak to our prescribers through a free consultation, reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.